Contact Person
    Nicole Mastrell

    Event Manager & PA to CEO
    Phone: (M) +45 6141 8634 Linkedin

    8th Annual Biologics Symposium and Potency assay 101 workshop

    Join the Annual Biologics Symposium to discuss the latest advances in the biologics field

    The Annual Biologics Symposium is back for its eighth year, and we’re confident that 2018 is going to be the most inspiring year yet!

    This two day educational event brings together peers from across the biologics community to share information and discuss real life research, techniques and challenges in biological drug development.

    Date: Thu, Mar 1  – Fri, Mar 2, 2018
    Time: 9:00 – 17:00
    Venue: Savoy Place, 2 Savoy Place, London, WC2R 0BL, United Kingdom


    Initial list of confirmed speakers

    We are delighted to have the following speakers confirmed for the symposium:

    Dr. Richard Sainson – Director in Pharmacology and Translational Sciences, Kymab Ltd

    KY1044, a novel anti-ICOS antibody, elicits long term in vivo anti-tumour efficacy as monotherapy or in combination with immune checkpoint inhibitors

    Dr. Mark Aspinall-O’Dea – EMEA Business Development Manager, Retrogenix Ltd

    Identifying critical target receptors and assessing specificity of biologics using cell microarray technology

    Dr. Rocky Cranenburgh – Chief Scientific Officer, Prokarium Ltd

    The Vaxonella platform for oral vaccine delivery using Salmonella

    Dr. Katja Fiedler – Scientist, CureVac

    Intratumoral RNA therapy for solid tumors

    Dr. Tomáš Hanke – Professor in Vaccine Immunology, University of Oxford

    HIV-1 Vaccines: Dealing with Diversity

    Dr. Anne Goubier – VP Immunology, Tusk Therapeutics

    Targeting CD38 beyond haematological malignancies: a panel of anti-CD38 antibodies with unique functional properties

    Dr. Frank Brennan – Senior Director, UCB Celltech

    Safety Assessment of Monoclonal Antibodies (mAbs); Challenges and Opportunities to Optimize What We Do

    Dr. Marinee Chuah – Deputy Director Department of Gene Therapy & Regenerative Medicine, Professor – Faculty of Medicine & Pharmacy, Free University of Brussels

    Next-generation Gene Therapy Products for muscle disorders

    Dr. Neil Williams – Chief Scientific Officer/Founder, KWS BioTest

    Title TBC

    Daniel Rabbie, Regulatory Affairs Manager, The Cell and Gene Therapy Catapult

    Title TBC

    Further details will be added soon.